ADVOCACY
DNDi and the George Institute launched a new report on the challenges of registering new drugs for neglected diseases in the African context. There is a need to think about new mechanisms and pathways to ensure the urgent approval of new drugs! More
SLEEPING SICKNESS
Developed by DNDi and its partners, NECT, the first new treatment in 25 years against HAT or sleeping sickness, is now available. NECT cuts the cost of treatment, is more convenient for the patients, and significantly reduces the burden on health workers. More
CHAGAS
Join the global Chagas campaign, launched on July 9th 2009 More
VISCERAL LEISHMANIASIS
At the World Congress on Leishmaniasis held on Feb. 3-7 in India, DNDi organized two symposia on ongoing clinical studies and on early-stage R&D pipeline. More than 700 attendees from around the world gathered in this event. More
MALARIA
DNDi and its partners are working to ensure access of ASAQ and ASMQ, two antimalarial fixed-dose combination therapies launched in 2007 and 2008. More
Congressional Malaria & NTD Caucus Briefing, Washington Jointly with MSF and RTI, DNDi organised a briefing on “Controlling Deadly Neglected Tropical Diseases: Opportunities to Expand the U.S. Impact" to inform policymakers.
February 18-20, 2010
Cohred/NEPAD meeting, Pretoria DNDi participated in this meeting to debate on "Strengthening access to medicine and pharmaceutical innovation". DNDi and the George Institute launched on this occasion their report "Registering new drugs: The African context".
- March 15, 2010New agreement signed to join forces to tackle Chagas disease
- March 10, 2010Award of "Research Paper of the Year"
- January 29, 2010$10,000 challenge launched to fight infectious diseases affecting 30 million people
- November 20, 2009DNDi Receives $15M from the Bill and Melinda Gates Foundation
- November 18, 2009Pfizer and DNDi Advancing International Research Efforts in The Fight Against Neglected Tropical Diseases
| SITEMAP | COPYRIGHT | DISCLAIMER | PRIVACY | @ 2009 DNDi All rights reserved |